Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

The discovery of a series of genetic and serological markers associated with disease susceptibility and phenotype in inflammatory bowel disease has led to the prospect of an integrated classification system involving clinical, serological and genetic parameters. The Working Party has reviewed curren...

Full description

Saved in:
Bibliographic Details
Main Authors: Mark S Silverberg, Jack Satsangi, Tariq Ahmad, Ian DR Arnott, Charles N Bernstein, Steven R Brant, Renzo Caprilli, Jean-Frédéric Colombel, Christoph Gasche, Karel Geboes, Derek P Jewell, Amir Karban, Edward V Loftus, A Salvador Peña, Robert H Riddell, David B Sachar, Stefan Schreiber, A Hillary Steinhart, Stephan R Targan, Severine Vermeire, Bryan F Warren
Format: Article
Language:English
Published: Wiley 2005-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2005/269076
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550047861964800
author Mark S Silverberg
Jack Satsangi
Tariq Ahmad
Ian DR Arnott
Charles N Bernstein
Steven R Brant
Renzo Caprilli
Jean-Frédéric Colombel
Christoph Gasche
Karel Geboes
Derek P Jewell
Amir Karban
Edward V Loftus
A Salvador Peña
Robert H Riddell
David B Sachar
Stefan Schreiber
A Hillary Steinhart
Stephan R Targan
Severine Vermeire
Bryan F Warren
author_facet Mark S Silverberg
Jack Satsangi
Tariq Ahmad
Ian DR Arnott
Charles N Bernstein
Steven R Brant
Renzo Caprilli
Jean-Frédéric Colombel
Christoph Gasche
Karel Geboes
Derek P Jewell
Amir Karban
Edward V Loftus
A Salvador Peña
Robert H Riddell
David B Sachar
Stefan Schreiber
A Hillary Steinhart
Stephan R Targan
Severine Vermeire
Bryan F Warren
author_sort Mark S Silverberg
collection DOAJ
description The discovery of a series of genetic and serological markers associated with disease susceptibility and phenotype in inflammatory bowel disease has led to the prospect of an integrated classification system involving clinical, serological and genetic parameters. The Working Party has reviewed current clinical classification systems in Crohn’s disease, ulcerative colitis and indeterminate colitis, and provided recommendations for clinical classification in practice. Progress with respect to integrating serological and genetic markers has been examined in detail, and the implications are discussed. While an integrated system is not proposed for clinical use at present, the introduction of a widely acceptable clinical subclassification is strongly advocated, which would allow detailed correlations among serotype, genotype and clinical phenotype to be examined and confirmed in independent cohorts of patients and, thereby, provide a vital foundation for future work.
format Article
id doaj-art-168e8fa578624d5da5d8ebf28b2082c4
institution Kabale University
issn 0835-7900
language English
publishDate 2005-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-168e8fa578624d5da5d8ebf28b2082c42025-02-03T06:07:52ZengWileyCanadian Journal of Gastroenterology0835-79002005-01-0119Suppl A5A36A10.1155/2005/269076Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of GastroenterologyMark S Silverberg0Jack Satsangi1Tariq Ahmad2Ian DR Arnott3Charles N Bernstein4Steven R Brant5Renzo Caprilli6Jean-Frédéric Colombel7Christoph Gasche8Karel Geboes9Derek P Jewell10Amir Karban11Edward V Loftus12A Salvador Peña13Robert H Riddell14David B Sachar15Stefan Schreiber16A Hillary Steinhart17Stephan R Targan18Severine Vermeire19Bryan F Warren20Department of Medicine, Mount Sinai Hospital IBD Centre, University of Toronto, Toronto, Ontario, CanadaDepartment of Gastroenterology, Western General Hospital, University of Edinburgh, Edinburgh, UKGastroenterology Unit, University of Oxford, Gibson Laboratories, Radcliffe Infirmary, Oxford, UKDepartment of Gastroenterology, Western General Hospital, University of Edinburgh, Edinburgh, UKDepartment of Medicine, Section of Gastroenterology, University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, CanadaThe Harvey M and Lyn P Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, John Hopkins University School of Medicine, and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USADepartment of Clinical Sciences, University of Rome “La Sapienza”, Rome, ItalyDepartment of Hepatogastroenterology and Registre EPIMAD, Hôpital HURIEZ, CH et U Lille, FranceDivision of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaDepartment of Pathology, University Hospital, Leuven, BelgiumDepartment of Gastroenterology, University of Oxford, Oxford, UKDepartment of Gastroenterology, Rambam Medical Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, IsraelDivision of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USADepartment of Pathology, VU University Medical Centre, Amsterdam, The NetherlandsDepartment of Pathology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, CanadaMount Sinai School of Medicine, New York, USAInstitute for Clinical Molecular Biology, Christian-Albrechts-University, Kiel, GermanyDepartment of Medicine, Mount Sinai Hospital IBD Centre, University of Toronto, Toronto, Ontario, CanadaCedars-Sinai Division of Gastroenterology, Inflammatory Bowel Disease Center and Immunobiology Institute, UCLA School of Medicine, Los Angeles, California, USADivision of Gastroenterology, University Hospital Gasthuisberg, Leuven, BelgiumDepartment of Cellular Pathology, John Radcliffe Hospital, University of Oxford, Oxford, UKThe discovery of a series of genetic and serological markers associated with disease susceptibility and phenotype in inflammatory bowel disease has led to the prospect of an integrated classification system involving clinical, serological and genetic parameters. The Working Party has reviewed current clinical classification systems in Crohn’s disease, ulcerative colitis and indeterminate colitis, and provided recommendations for clinical classification in practice. Progress with respect to integrating serological and genetic markers has been examined in detail, and the implications are discussed. While an integrated system is not proposed for clinical use at present, the introduction of a widely acceptable clinical subclassification is strongly advocated, which would allow detailed correlations among serotype, genotype and clinical phenotype to be examined and confirmed in independent cohorts of patients and, thereby, provide a vital foundation for future work.http://dx.doi.org/10.1155/2005/269076
spellingShingle Mark S Silverberg
Jack Satsangi
Tariq Ahmad
Ian DR Arnott
Charles N Bernstein
Steven R Brant
Renzo Caprilli
Jean-Frédéric Colombel
Christoph Gasche
Karel Geboes
Derek P Jewell
Amir Karban
Edward V Loftus
A Salvador Peña
Robert H Riddell
David B Sachar
Stefan Schreiber
A Hillary Steinhart
Stephan R Targan
Severine Vermeire
Bryan F Warren
Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Canadian Journal of Gastroenterology
title Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
title_full Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
title_fullStr Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
title_full_unstemmed Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
title_short Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
title_sort toward an integrated clinical molecular and serological classification of inflammatory bowel disease report of a working party of the 2005 montreal world congress of gastroenterology
url http://dx.doi.org/10.1155/2005/269076
work_keys_str_mv AT markssilverberg towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT jacksatsangi towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT tariqahmad towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT iandrarnott towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT charlesnbernstein towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT stevenrbrant towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT renzocaprilli towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT jeanfredericcolombel towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT christophgasche towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT karelgeboes towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT derekpjewell towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT amirkarban towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT edwardvloftus towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT asalvadorpena towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT roberthriddell towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT davidbsachar towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT stefanschreiber towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT ahillarysteinhart towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT stephanrtargan towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT severinevermeire towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology
AT bryanfwarren towardanintegratedclinicalmolecularandserologicalclassificationofinflammatoryboweldiseasereportofaworkingpartyofthe2005montrealworldcongressofgastroenterology